Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pirfetab 801mg Tablet

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Pirfenidone (801mg)

Overview Pirfetab 801mg Tablet

Nintedanib 801mg tablets, a prescription medication, treat idiopathic pulmonary fibrosis. This medicine lessens lung inflammation and scarring, improving breathing. For optimal results, take Nintedanib 801mg with food at the same time daily. Dosage frequency varies depending on individual needs; your physician will determine the appropriate regimen to manage your symptoms. Continue treatment as directed by your doctor. Common side effects include sleep disturbances, headaches, vertigo, indigestion, nausea, diarrhea, and sun sensitivity. To minimize dizziness, avoid driving or activities requiring focus. Weight loss is possible; regular monitoring or consultation with your doctor is advised. Liver function tests may be conducted during treatment. Before starting, inform your physician about any liver or kidney conditions, and all other medications you're taking, as interactions may affect efficacy. Due to increased sun sensitivity, wear protective clothing and sunscreen when exposed to sunlight. Notify your doctor if you're pregnant or nursing.

Uses of Pirfetab 801mg Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Pirfetab 801mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Pirfetab 801mg Tablet should be administered with a meal.

Common Side effects of Pirfetab 801mg Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Pirfetab 801mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Pirfetab 801mg Tablet should be administered with a meal.

How Pirfetab 801mg Tablet works:

Pirfenidone 801mg tablets are an antifibrotic agent. Their mechanism of action involves inhibiting a specific endogenous compound implicated in fibrogenesis, thereby lessening pulmonary scarring and inflammation, and improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol and Pirfetab 801mg Tablet is currently undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Pirfetab 801mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Pirfetab 801mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking an 801mg Pirfetab tablet might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Caution is advised when prescribing Pirfetab 801mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients should seek medical advice. Pirfetab 801mg tablets are contraindicated in patients with severe kidney disease or those undergoing dialysis.

LiverLiverCAUTION

Patients with liver impairment should use 801mg Pirfetab tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Pirfetab 801mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Pirfetab 801mg Tablet :

NA

Facts to Know About Pirfetab 801mg Tablet

LabelValue
Chemical Type Pyridone Derivative
Developing Habits No.
Treatment Category Breathing
Action Class Pulmonary fibrosis of unknown cause

FAQs on Pirfetab 801mg Tablet

Before starting Pirfetab 801mg Tablet treatment, your doctor will assess your liver function. This will be monitored monthly for six months, then quarterly thereafter. Your lung function will also be periodically assessed to track your response to the medication.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, your doctor's prescribed treatment with Pirfetab 801mg Tablet should be started and continued to help maintain your current lung capacity.
Pirfetab 801mg Tablet may cause sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other possible side effects include upper respiratory and bladder infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, shortness of breath, and cough. Gastrointestinal issues like acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions such as itching, redness, dryness, and rash are possible, along with muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzyme levels may be detected in blood tests.
Pirfetab 801mg tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, impairing breathing. This medication helps alleviate these effects, improving breathing.
You and your doctor should determine if Pirfetab 801mg Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your health. Continued use depends on your response and tolerance to the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Never discontinue Pirfetab 801mg Tablet without your doctor's advice. Continued use may help slow disease progression.
Minimize sun exposure while using Pirfetab 801mg Tablet. Daily sunscreen use and covering exposed skin are recommended. Also avoid smoking, as it can reduce Pirfetab's effectiveness.
While the average lifespan for pulmonary fibrosis patients is two to three years, some individuals survive significantly longer. Reduced survival is associated with older age, smoking, and lower body mass index. Further contributing factors include advanced disease severity (both radiologically and functionally) and the onset of additional lung problems.
Pirfetab 801mg Tablet
689
MRP 798
13% off